|Awarded On||May 18, 2016|
|Title||Integrated-cavity-enhanced pre-screening for lung cancer|
|Award Mechanism||High Impact/High Risk|
|Institution/Organization||Texas A&M University|
|Principal Investigator/Program Director||Vladislav Yakovlev|
|Cancer Sites||Lung and Bronchus|
Lung cancer is the leading cause of cancer mortality in the United States. Early diagnosis is documented to lead to significantly higher rates of patients’ survival. Only 15% of lung cancer cases are diagnosed this way. Currently, most medical practices use plain film PA and lateral chest x-ray as a screening method. However, the sensitivity and specificity of these plain films are poor, especially for early stage disease. Data suggests Computed Tomography (CT) is cost effective over time as a screening modality but acceptance has been slow due to initial higher cost and concerns over increased dosage of ionizing radiation. Widespread use of CT scanning has been shown to result in an increas...